GenSight Biologics Unveils New Scientific Findings on LUMEVOQ™ at NANOS 2025 Conference
GenSight Biologics to Present New Data on LUMEVOQ® at NANOS Annual Meeting GenSight Biologics, a pioneering biopharma company specializing in the discovery and development of innovative gene therapies for retinal neurodegenerative diseases and central nervous system disorders, recently announced that new scientific data and analyses on their gene therapy LUMEVOQ® will be presented at the…